Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-10-7
pubmed:abstractText
The objective of this study was to assess the impact of surgical cytoreduction on the survival of patients with uterine papillary serous carcinoma (UPSC). Patients added to the institutional tumor registries between January 1980 and September 2001 with the diagnosis of UPSC were reviewed. The records of 43 patients who underwent surgical cytoreduction for FIGO stage III and IV disease were reviewed. The median survival of UPSC patients with microscopic residual disease was significantly improved compared to those with macroscopic residual disease following primary surgical cytoreduction. We conclude that primary surgical cytoreduction resulting in microscopic residual disease is associated with an improvement in recurrence-free survival and overall survival in women with UPSC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1048-891X
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
454-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12366662-Adult, pubmed-meshheading:12366662-Aged, pubmed-meshheading:12366662-Aged, 80 and over, pubmed-meshheading:12366662-Biopsy, Needle, pubmed-meshheading:12366662-Chi-Square Distribution, pubmed-meshheading:12366662-Cystadenocarcinoma, Papillary, pubmed-meshheading:12366662-Disease-Free Survival, pubmed-meshheading:12366662-Female, pubmed-meshheading:12366662-Humans, pubmed-meshheading:12366662-Hysterectomy, pubmed-meshheading:12366662-Middle Aged, pubmed-meshheading:12366662-Neoplasm, Residual, pubmed-meshheading:12366662-Neoplasm Staging, pubmed-meshheading:12366662-Probability, pubmed-meshheading:12366662-Prognosis, pubmed-meshheading:12366662-Retrospective Studies, pubmed-meshheading:12366662-Risk Assessment, pubmed-meshheading:12366662-Sensitivity and Specificity, pubmed-meshheading:12366662-Survival Analysis, pubmed-meshheading:12366662-Uterine Neoplasms
pubmed:articleTitle
FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.
pubmed:affiliation
Division of Gynecologic Oncology, UCLA School of Medicine, Los Angeles, California 90095-1740, USA.
pubmed:publicationType
Journal Article, Comparative Study